These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 39114974)

  • 1. Game of microbes: the battle within - gut microbiota and multiple sclerosis.
    Turner TA; Lehman P; Ghimire S; Shahi SK; Mangalam A
    Gut Microbes; 2024; 16(1):2387794. PubMed ID: 39114974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet-microbiome-immune interplay in multiple sclerosis: Understanding the impact of phytoestrogen metabolizing gut bacteria.
    Lehman PC; Ghimire S; Price JD; Ramer-Tait AE; Mangalam AK
    Eur J Immunol; 2023 Nov; 53(11):e2250236. PubMed ID: 37673213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
    Shahi SK; Freedman SN; Mangalam AK
    Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet.
    Montgomery TL; Peipert D; Krementsov DN
    Immunol Rev; 2024 Aug; 325(1):131-151. PubMed ID: 38717158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the gut microbiome in multiple sclerosis: From etiology to therapeutics.
    Shahi SK; Yadav M; Ghimire S; Mangalam AK
    Int Rev Neurobiol; 2022; 167():185-215. PubMed ID: 36427955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis.
    Shahi SK; Ghimire S; Lehman P; Mangalam AK
    Front Immunol; 2022; 13():966417. PubMed ID: 36164343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
    Freedman SN; Shahi SK; Mangalam AK
    Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
    Montgomery TL; Künstner A; Kennedy JJ; Fang Q; Asarian L; Culp-Hill R; D'Alessandro A; Teuscher C; Busch H; Krementsov DN
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27516-27527. PubMed ID: 33077601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
    Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
    Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA Class II Polymorphisms Modulate Gut Microbiota and Experimental Autoimmune Encephalomyelitis Phenotype.
    Shahi SK; Ali S; Jaime CM; Guseva NV; Mangalam AK
    Immunohorizons; 2021 Aug; 5(8):627-646. PubMed ID: 34380664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
    Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
    Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis.
    Fettig NM; Osborne LC
    Microbes Infect; 2021; 23(6-7):104814. PubMed ID: 33775860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
    Wing AC; Kremenchutzky M
    Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
    Yadav SK; Ito K; Dhib-Jalbut S
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut dysbiosis and multiple sclerosis.
    Noto D; Miyake S
    Clin Immunol; 2022 Feb; 235():108380. PubMed ID: 32169440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.
    Mowry EM; Glenn JD
    Neurol Clin; 2018 Feb; 36(1):185-196. PubMed ID: 29157399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut Microbiome and Multiple Sclerosis.
    Ochoa-Repáraz J; Kirby TO; Kasper LH
    Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 29311123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis.
    Ladakis DC; Bhargava P
    CNS Drugs; 2023 Feb; 37(2):117-132. PubMed ID: 36690786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.
    Maglione A; Zuccalà M; Tosi M; Clerico M; Rolla S
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations: Associations with Ethnicity, Gender, Disability Status, Vitamin D Levels, and Mediterranean Diet.
    Nitzan Z; Staun-Ram E; Volkowich A; Miller A
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.